In vitro evaluation of the hyaluronic acid/alginate composite powder for topical haemostasis and wound healing
The use of haemostatic agents can provide life‐saving treatment for patients who suffer from massive bleeding in both prehospital and intraoperative conditions. However, there are still urgent demands for novel haemostatic materials that exhibit better haemostatic activity, biocompatibility, and bio...
Saved in:
Published in | International wound journal Vol. 17; no. 2; pp. 394 - 404 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Blackwell Publishing Ltd
01.04.2020
|
Subjects | |
Online Access | Get full text |
ISSN | 1742-4801 1742-481X 1742-481X |
DOI | 10.1111/iwj.13285 |
Cover
Abstract | The use of haemostatic agents can provide life‐saving treatment for patients who suffer from massive bleeding in both prehospital and intraoperative conditions. However, there are still urgent demands for novel haemostatic materials that exhibit better haemostatic activity, biocompatibility, and biodegradability than existing products. In the present study, we aim to evaluate the feasibility of new wound dressing, RapidClot, for treating uncontrolled haemorrhage through a series of in vitro assessments to determine the swelling ratio, clotting time, enzymatic degradation, haemolytic activity, cytotoxicity, cell proliferation, and migration. The results indicated that the RapidClot revealed better water adsorption capacity and shorter blood clotting time (132.7 seconds) than two commercially available haemostatic agents Celox (378.7 seconds) and WoundSeal (705.3 seconds). Additionally, the RapidClot dressing exhibited a similar level of degradability in the presence of hyaluronidase and lysozyme as that of Celox, whereas negligible degradation of WoundSeal was obtained. Although both Celox and RapidClot revealed a similar level in cell viability (above than 90%) against NIH/3 T3 fibroblasts, improved cell proliferation and migration could be obtained in RapidClot. Taking together, our results demonstrated that RapidClot could possess a great potential for serving as an efficient healing dressing with haemorrhage control ability. |
---|---|
AbstractList | The use of haemostatic agents can provide life‐saving treatment for patients who suffer from massive bleeding in both prehospital and intraoperative conditions. However, there are still urgent demands for novel haemostatic materials that exhibit better haemostatic activity, biocompatibility, and biodegradability than existing products. In the present study, we aim to evaluate the feasibility of new wound dressing, RapidClot, for treating uncontrolled haemorrhage through a series of in vitro assessments to determine the swelling ratio, clotting time, enzymatic degradation, haemolytic activity, cytotoxicity, cell proliferation, and migration. The results indicated that the RapidClot revealed better water adsorption capacity and shorter blood clotting time (132.7 seconds) than two commercially available haemostatic agents Celox (378.7 seconds) and WoundSeal (705.3 seconds). Additionally, the RapidClot dressing exhibited a similar level of degradability in the presence of hyaluronidase and lysozyme as that of Celox, whereas negligible degradation of WoundSeal was obtained. Although both Celox and RapidClot revealed a similar level in cell viability (above than 90%) against NIH/3 T3 fibroblasts, improved cell proliferation and migration could be obtained in RapidClot. Taking together, our results demonstrated that RapidClot could possess a great potential for serving as an efficient healing dressing with haemorrhage control ability. The use of haemostatic agents can provide life-saving treatment for patients who suffer from massive bleeding in both prehospital and intraoperative conditions. However, there are still urgent demands for novel haemostatic materials that exhibit better haemostatic activity, biocompatibility, and biodegradability than existing products. In the present study, we aim to evaluate the feasibility of new wound dressing, RapidClot, for treating uncontrolled haemorrhage through a series of in vitro assessments to determine the swelling ratio, clotting time, enzymatic degradation, haemolytic activity, cytotoxicity, cell proliferation, and migration. The results indicated that the RapidClot revealed better water adsorption capacity and shorter blood clotting time (132.7 seconds) than two commercially available haemostatic agents Celox (378.7 seconds) and WoundSeal (705.3 seconds). Additionally, the RapidClot dressing exhibited a similar level of degradability in the presence of hyaluronidase and lysozyme as that of Celox, whereas negligible degradation of WoundSeal was obtained. Although both Celox and RapidClot revealed a similar level in cell viability (above than 90%) against NIH/3 T3 fibroblasts, improved cell proliferation and migration could be obtained in RapidClot. Taking together, our results demonstrated that RapidClot could possess a great potential for serving as an efficient healing dressing with haemorrhage control ability.The use of haemostatic agents can provide life-saving treatment for patients who suffer from massive bleeding in both prehospital and intraoperative conditions. However, there are still urgent demands for novel haemostatic materials that exhibit better haemostatic activity, biocompatibility, and biodegradability than existing products. In the present study, we aim to evaluate the feasibility of new wound dressing, RapidClot, for treating uncontrolled haemorrhage through a series of in vitro assessments to determine the swelling ratio, clotting time, enzymatic degradation, haemolytic activity, cytotoxicity, cell proliferation, and migration. The results indicated that the RapidClot revealed better water adsorption capacity and shorter blood clotting time (132.7 seconds) than two commercially available haemostatic agents Celox (378.7 seconds) and WoundSeal (705.3 seconds). Additionally, the RapidClot dressing exhibited a similar level of degradability in the presence of hyaluronidase and lysozyme as that of Celox, whereas negligible degradation of WoundSeal was obtained. Although both Celox and RapidClot revealed a similar level in cell viability (above than 90%) against NIH/3 T3 fibroblasts, improved cell proliferation and migration could be obtained in RapidClot. Taking together, our results demonstrated that RapidClot could possess a great potential for serving as an efficient healing dressing with haemorrhage control ability. |
Author | Chuang, Ching‐Kuang Ho, Chia‐Che Chen, Chia‐Hui Shen, Meng‐Han Lu, Chia‐Hsin Chen, Yi‐Wen Lin, Shih‐Yeh |
AuthorAffiliation | 1 Graduate Institute of Biomedical Sciences China Medical University Taichung City Taiwan 4 Department of Bioinformatics and Medical Engineering Asia University Taichung City Taiwan 2 3D Printing Medical Research Center China Medical University Hospital Taichung City Taiwan 3 Research and Development Division Jing‐Te Biomedical Technology Co., Ltd. Taichung City Taiwan |
AuthorAffiliation_xml | – name: 4 Department of Bioinformatics and Medical Engineering Asia University Taichung City Taiwan – name: 1 Graduate Institute of Biomedical Sciences China Medical University Taichung City Taiwan – name: 2 3D Printing Medical Research Center China Medical University Hospital Taichung City Taiwan – name: 3 Research and Development Division Jing‐Te Biomedical Technology Co., Ltd. Taichung City Taiwan |
Author_xml | – sequence: 1 givenname: Yi‐Wen surname: Chen fullname: Chen, Yi‐Wen organization: China Medical University Hospital – sequence: 2 givenname: Chia‐Hsin surname: Lu fullname: Lu, Chia‐Hsin organization: Jing‐Te Biomedical Technology Co., Ltd – sequence: 3 givenname: Meng‐Han surname: Shen fullname: Shen, Meng‐Han organization: Jing‐Te Biomedical Technology Co., Ltd – sequence: 4 givenname: Shih‐Yeh surname: Lin fullname: Lin, Shih‐Yeh organization: Jing‐Te Biomedical Technology Co., Ltd – sequence: 5 givenname: Chia‐Hui surname: Chen fullname: Chen, Chia‐Hui organization: Jing‐Te Biomedical Technology Co., Ltd – sequence: 6 givenname: Ching‐Kuang surname: Chuang fullname: Chuang, Ching‐Kuang email: kevinchuang@dehlab.com organization: Jing‐Te Biomedical Technology Co., Ltd – sequence: 7 givenname: Chia‐Che orcidid: 0000-0002-2825-3398 surname: Ho fullname: Ho, Chia‐Che email: sfox1223@gmail.com organization: Asia University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31845534$$D View this record in MEDLINE/PubMed |
BookMark | eNp9UU1v1DAQtVAR_YADfwD5CJW2azv2JrkgVRUfiypxAcHNmjiTjSvHDnayq_33uN1SPiTqgz0av_dm5s0pOfLBIyEvObvg-Szt7uaCF6JST8gJL6VYyIp_P3qIGT8mpyndMCZqpcpn5LjglVSqkCfErz3d2ikGiltwM0w2eBo6OvVI-33OxOCtoWBsuwS3sR4mpCYMY0g2R2PYtRhpFyKdwmgNONoDDiFNkGyi4Fu6C3O-ewRn_eY5edqBS_ji_j0jX9-_-3L1cXH9-cP66vJ6YSRXaqHqVopS8ZXMY5UMAWvRMglNzZVpZAFM8hpM3TDBsWl404murAohKmAKi6I4I-cH3dmPsN-Bc3qMdoC415zpW9N0Nk3fmZbBbw_gcW4GbA36KcJvQgCr__7xttebsNVlLWuxWmWB1_cCMfyYMU16sMmgc-AxzEmLPEQt-UrJDH31Z62HIr82kgFvDgATQ0oRu0cbX_6DNXa6W2Fu07rHGDvrcP9_ab3-9unA-AmkrrzD |
CitedBy_id | crossref_primary_10_1016_j_powtec_2023_118501 crossref_primary_10_1016_j_bioadv_2022_212805 crossref_primary_10_1177_08853282221076708 crossref_primary_10_1177_03913988241280202 crossref_primary_10_1007_s11051_021_05345_8 crossref_primary_10_1016_j_eurpolymj_2021_110784 crossref_primary_10_1016_j_ijbiomac_2024_130771 crossref_primary_10_1016_j_ijbiomac_2024_139377 crossref_primary_10_3390_molecules29132999 crossref_primary_10_1007_s10570_021_04132_x crossref_primary_10_1002_adhm_202301370 crossref_primary_10_1111_iwj_14644 crossref_primary_10_1002_adfm_202409231 crossref_primary_10_3390_molecules26051355 crossref_primary_10_1016_j_jddst_2021_102890 crossref_primary_10_1016_j_jobcr_2024_02_010 crossref_primary_10_1016_j_ibiod_2023_105594 crossref_primary_10_1097_01_ASW_0000790488_72494_57 crossref_primary_10_1177_08839115221147935 crossref_primary_10_1016_j_ijbiomac_2024_129752 crossref_primary_10_1016_j_sajb_2021_03_036 |
Cites_doi | 10.1111/j.1524-475X.2007.00342.x 10.1097/TA.0b013e31812f6dbc 10.1038/s41467-018-04998-9 10.3390/jfb5040273 10.1016/j.ijbiomac.2018.11.186 10.7205/MILMED-D-11-00310 10.1016/j.polymer.2005.03.072 10.1002/mabi.201800209 10.1001/jamadermatol.2013.2620 10.1016/j.resuscitation.2008.02.019 10.1097/TA.0b013e31819634a1 10.1007/s40140-014-0063-8 10.1016/j.actbio.2011.03.003 10.1038/aps.2012.159 10.1016/j.biomaterials.2008.07.034 10.1016/j.jaad.2011.06.028 10.1002/(SICI)1097-4652(199905)179:2<142::AID-JCP4>3.0.CO;2-Q 10.1134/S1560090408070038 10.1006/jsre.1996.0379 10.1097/TA.0b013e3181c452b5 10.1016/j.athoracsur.2005.03.051 10.1016/j.carbpol.2019.05.035 10.1039/C6RA20782K 10.1021/la701281t 10.1097/01.ta.0000199961.02677.19 10.1002/(SICI)1097-4628(19991220)74:13<3186::AID-APP22>3.0.CO;2-Y 10.1002/adfm.201704452 10.1097/TA.0000000000001075 10.1097/TA.0b013e31805f7023 10.1002/adma.201301034 10.1592/phco.29.pt2.8S 10.1021/acsbiomaterials.8b00453 10.1080/10903120601021176 10.1021/cm071457b |
ContentType | Journal Article |
Copyright | 2019 Medicalhelplines.com Inc and John Wiley & Sons Ltd 2019 Medicalhelplines.com Inc and John Wiley & Sons Ltd. |
Copyright_xml | – notice: 2019 Medicalhelplines.com Inc and John Wiley & Sons Ltd – notice: 2019 Medicalhelplines.com Inc and John Wiley & Sons Ltd. |
DBID | AAYXX CITATION NPM 7X8 5PM ADTOC UNPAY |
DOI | 10.1111/iwj.13285 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | CrossRef PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
DocumentTitleAlternate | Chen et al |
EISSN | 1742-481X |
EndPage | 404 |
ExternalDocumentID | 10.1111/iwj.13285 PMC7949266 31845534 10_1111_iwj_13285 IWJ13285 |
Genre | article Journal Article |
GrantInformation_xml | – fundername: China Medical University Hospital funderid: DMR‐108‐002 – fundername: Ministry of Economic Affairs funderid: 1Z1050357 – fundername: China Medical University Hospital grantid: DMR-108-002 – fundername: Ministry of Economic Affairs grantid: 1Z1050357 – fundername: ; grantid: DMR‐108‐002 – fundername: ; grantid: 1Z1050357 |
GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 1OC 24P 29J 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 6PF 702 7PT 7X7 8-0 8-1 8-3 8-4 8-5 8FI 8FJ 8UM 930 A01 A03 AAESR AAEVG AAHHS AANHP AAONW AAWTL AAZKR ABCQN ABCUV ABEML ABPVW ABUWG ACBWZ ACCFJ ACCMX ACGFO ACGFS ACMXC ACPOU ACRPL ACSCC ACXQS ACYXJ ADBBV ADEOM ADIZJ ADKYN ADMGS ADNMO ADPDF ADXAS ADZMN ADZOD AEEZP AEIMD AENEX AEQDE AEUQT AFBPY AFEBI AFGKR AFKRA AFPWT AIAGR AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVUZU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BENPR BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG CCPQU COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM EBS EJD EMOBN F00 F01 F04 F5P FEDTE FUBAC FYUFA G-S G.N GODZA GROUPED_DOAJ H.X HF~ HMCUK HVGLF HZ~ IAO IHE IHR INH IX1 J0M LATKE LC2 LC3 LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NAPCQ NF~ O66 O9- OIG OK1 OVD OVEED P2P P2W P2X P2Z P4B P4D Q.N Q11 QB0 R.K ROL RPM RX1 SUPJJ TEORI UB1 UKHRP V8K W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WQ9 WQJ WRC WVDHM WXI XG1 YCJ ZZTAW ~IA ~WT AAMMB AAYXX AEFGJ AGQPQ AGXDD AIDQK AIDYY CITATION PHGZM PHGZT PPXIY PUEGO WIN NPM 7X8 5PM ADTOC UNPAY |
ID | FETCH-LOGICAL-c4155-59d427516413270eae92d04ab915cb43a0419ac9b021ebb1bf2f783228a05e333 |
IEDL.DBID | UNPAY |
ISSN | 1742-4801 1742-481X |
IngestDate | Wed Aug 20 00:15:40 EDT 2025 Tue Sep 30 16:20:43 EDT 2025 Fri Sep 05 10:07:40 EDT 2025 Thu Apr 03 06:52:35 EDT 2025 Wed Oct 01 06:27:16 EDT 2025 Thu Apr 24 23:09:06 EDT 2025 Wed Jan 22 16:36:50 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | haemostatic powder cytocompatibility haemorrhage control biodegradation fibroblast |
Language | English |
License | 2019 Medicalhelplines.com Inc and John Wiley & Sons Ltd. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4155-59d427516413270eae92d04ab915cb43a0419ac9b021ebb1bf2f783228a05e333 |
Notes | Funding information China Medical University Hospital, Grant/Award Number: DMR‐108‐002; Ministry of Economic Affairs, Grant/Award Number: 1Z1050357 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Funding information China Medical University Hospital, Grant/Award Number: DMR‐108‐002; Ministry of Economic Affairs, Grant/Award Number: 1Z1050357 |
ORCID | 0000-0002-2825-3398 |
OpenAccessLink | https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/iwj.13285 |
PMID | 31845534 |
PQID | 2327941654 |
PQPubID | 23479 |
PageCount | 11 |
ParticipantIDs | unpaywall_primary_10_1111_iwj_13285 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7949266 proquest_miscellaneous_2327941654 pubmed_primary_31845534 crossref_primary_10_1111_iwj_13285 crossref_citationtrail_10_1111_iwj_13285 wiley_primary_10_1111_iwj_13285_IWJ13285 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | April 2020 |
PublicationDateYYYYMMDD | 2020-04-01 |
PublicationDate_xml | – month: 04 year: 2020 text: April 2020 |
PublicationDecade | 2020 |
PublicationPlace | Oxford, UK |
PublicationPlace_xml | – name: Oxford, UK – name: England |
PublicationTitle | International wound journal |
PublicationTitleAlternate | Int Wound J |
PublicationYear | 2020 |
Publisher | Blackwell Publishing Ltd |
Publisher_xml | – name: Blackwell Publishing Ltd |
References | 2009; 66 2007; 19 2015; 17 2013; 25 2011; 2 2013; 68 2017; 28 2013; 149 2008; 16 2008; 78 2008; 50 2007; 11 2019; 221 2011; 7 2019; 123 2009; 29 2005; 46 2006; 81 2006; 60 2018; 18 2018; 9 2016; 6 2010; 20 2014; 5 2014; 4 2012; 177 2010; 69 2018; 4 2013; 34 2008; 29 1999; 179 1999; 74 2016; 81 2008; 64 2007; 63 2007; 23 1996; 66 e_1_2_7_6_1 e_1_2_7_5_1 e_1_2_7_3_1 Emmez H (e_1_2_7_25_1) 2010; 20 e_1_2_7_9_1 e_1_2_7_8_1 e_1_2_7_7_1 e_1_2_7_19_1 e_1_2_7_18_1 e_1_2_7_17_1 e_1_2_7_16_1 e_1_2_7_2_1 e_1_2_7_15_1 e_1_2_7_14_1 e_1_2_7_13_1 e_1_2_7_12_1 e_1_2_7_11_1 e_1_2_7_10_1 e_1_2_7_27_1 e_1_2_7_28_1 e_1_2_7_29_1 Kheirabadi B (e_1_2_7_26_1) 2011; 2 e_1_2_7_30_1 e_1_2_7_31_1 e_1_2_7_24_1 e_1_2_7_32_1 e_1_2_7_23_1 e_1_2_7_33_1 e_1_2_7_22_1 e_1_2_7_34_1 e_1_2_7_21_1 e_1_2_7_35_1 e_1_2_7_20_1 e_1_2_7_36_1 e_1_2_7_37_1 e_1_2_7_38_1 Kommu SS (e_1_2_7_4_1) 2015; 17 |
References_xml | – volume: 6 year: 2016 article-title: Preparation and characterization of a chitin/platelet‐poor plasma composite as a hemostatic material publication-title: RSC Adv – volume: 46 start-page: 4676 year: 2005 end-page: 4685 article-title: Concurrent effect of microporosity and chemical structure on the equilibrium sorption properties of cellulose‐based hydrogels publication-title: Polymer – volume: 123 start-page: 1204 year: 2019 end-page: 1210 article-title: Evaluation of modified hyaluronic acid in terms of rheology, enzymatic degradation and mucoadhesion publication-title: Int J Biol Macromol – volume: 81 start-page: 1499 year: 2006 end-page: 1500 article-title: Acute intraoperative malfunction of aortic valve due to surgical glue publication-title: Ann Thorac Surg – volume: 149 start-page: 632 year: 2013 article-title: Foreign‐body reaction to wound seal publication-title: JAMA Dermatol – volume: 64 start-page: 1093 year: 2008 end-page: 1099 article-title: QuikClot use in trauma for hemorrhage control: case series of 103 documented uses publication-title: J Trauma – volume: 7 start-page: 2558 year: 2011 end-page: 2565 article-title: In vitro and in vivo evaluation of chemically modified degradable starch microspheres for topical haemostasis publication-title: Acta Biomater – volume: 69 start-page: 1203 year: 2010 end-page: 1209 article-title: Preliminary study of the effects of smectite granules (WoundStat) on vascular repair and wound healing in a swine survival model publication-title: J Trauma – volume: 11 start-page: 67 year: 2007 end-page: 71 article-title: A case series describing thermal injury resulting from zeolite use for hemorrhage control in combat operations publication-title: Prehosp Emerg Care – volume: 23 year: 2007 article-title: Metal oxide surface charge mediated hemostasis publication-title: Langmuir – volume: 50 start-page: 172 year: 2008 end-page: 174 article-title: Macromolecular effects upon enzymatic degradation of chitosan in solution publication-title: Polym Sci Ser B – volume: 16 start-page: 274 year: 2008 end-page: 287 article-title: Differential effects of hyaluronan and its fragments on fibroblasts: relation to wound healing publication-title: Wound Repair Regen – volume: 25 start-page: 4069 year: 2013 end-page: 4086 article-title: Clay: new opportunities for tissue regeneration and biomaterial design publication-title: Adv Mater – volume: 19 start-page: 4390 year: 2007 end-page: 4392 article-title: Controlling bioprocesses with inorganic surfaces: layered clay hemostatic agents publication-title: Chem Mater – volume: 60 start-page: S3 year: 2006 end-page: S11 article-title: Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations publication-title: J Trauma – volume: 68 start-page: e117 year: 2013 end-page: e126 article-title: The local treatment and available dressings designed for chronic wounds publication-title: J Am Acad Dermatol – volume: 66 start-page: 100 year: 1996 end-page: 108 article-title: Comparative in vitro analysis of topical hemostatic agents publication-title: J Surg Res – volume: 34 start-page: 367 year: 2013 end-page: 372 article-title: Zeolite‐based hemostat QuikClot releases calcium into blood and promotes blood coagulation in vitro publication-title: Acta Pharmacol Sin – volume: 66 start-page: 316 year: 2009 end-page: 326 article-title: Comparison of new hemostatic granules/powders with currently deployed hemostatic products in a lethal model of extremity arterial hemorrhage in swine publication-title: J Trauma – volume: 18 year: 2018 article-title: Tannic acid cross‐linked polysaccharide‐based multifunctional hemostatic microparticles for the regulation of rapid wound healing publication-title: Macromol Biosci – volume: 28 year: 2017 article-title: Emerging nanoclay composite for effective hemostasis publication-title: Adv Funct Mater – volume: 29 start-page: 8S year: 2009 end-page: 12S article-title: Topical thrombins: benefits and risks publication-title: Pharmacotherapy – volume: 4 start-page: 189 year: 2014 end-page: 199 article-title: Trauma‐induced coagulopathy publication-title: Curr Anesthesiol Rep – volume: 17 start-page: 150 year: 2015 end-page: 159 article-title: Current status of hemostatic agents and sealants in urologic surgical practice publication-title: Rev Urol – volume: 177 start-page: 340 year: 2012 end-page: 344 article-title: The effects of arterial blood pressure on rebleeding when BleedArrest, CX and TraumaDex are used in a porcine model of lethal femoral injury publication-title: Mil Med – volume: 29 start-page: 4323 issue: 32 year: 2008 end-page: 4332 article-title: Development of a chitosan‐based wound dressing with improved hemostatic and antimicrobial properties publication-title: Biomaterials – volume: 4 start-page: 2541 year: 2018 end-page: 2551 article-title: Microspheres of carboxymethyl chitosan, sodium alginate, and collagen as a hemostatic agent in vivo publication-title: ACS Biomater Sci Eng – volume: 2 start-page: 25 year: 2011 end-page: 37 article-title: Evaluation of topical hemostatic agents for combat wound treatment publication-title: US Army Med Dep J – volume: 81 start-page: 294 year: 2016 end-page: 301 article-title: Extending resuscitative endovascular balloon occlusion of the aorta: endovascular variable aortic control in a lethal model of hemorrhagic shock publication-title: J Trauma Acute Care Surg – volume: 74 start-page: 3186 year: 1999 end-page: 3192 article-title: Structural change and swelling mechanism of pH‐sensitive hydrogels based on chitosan and D,L‐lactic acid publication-title: J Appl Polym Sci – volume: 9 year: 2018 article-title: Injectable antibacterial conductive nanocomposite cryogels with rapid shape recovery for noncompressible hemorrhage and wound healing publication-title: Nat Commun – volume: 5 start-page: 273 year: 2014 end-page: 287 article-title: Electrokinetic and hemostatic profiles of nonwoven cellulosic/synthetic fiber blends with unbleached cotton publication-title: J Funct Biomater – volume: 20 start-page: 485 year: 2010 end-page: 491 article-title: Radiological and histopathological comparison of microporous polysaccharide hemospheres and oxidized regenerated cellulose in the rabbit brain: a study of efficacy and safety publication-title: Turk Neurosurg – volume: 221 start-page: 21 year: 2019 end-page: 28 article-title: In situ synthesis of poly (γ‐glutamic acid)/alginate/AgNP composite microspheres with antibacterial and hemostatic properties publication-title: Carbohydr Polym – volume: 63 start-page: 775 year: 2007 end-page: 782 article-title: Comparative efficacy of granular and bagged formulations of the hemostatic agent QuikClot publication-title: J Trauma – volume: 78 start-page: 230 year: 2008 end-page: 235 article-title: Comparison of a new mineral based hemostatic agent to a commercially available granular zeolite agent for hemostasis in a swine model of lethal extremity arterial hemorrhage publication-title: Resuscitation – volume: 179 start-page: 142 year: 1999 end-page: 148 article-title: Hyaluronic acid enhances proliferation and chondroitin sulfate synthesis in cultured chondrocytes embedded in collagen gels publication-title: J Cell Physiol – ident: e_1_2_7_38_1 doi: 10.1111/j.1524-475X.2007.00342.x – ident: e_1_2_7_9_1 doi: 10.1097/TA.0b013e31812f6dbc – ident: e_1_2_7_27_1 doi: 10.1038/s41467-018-04998-9 – ident: e_1_2_7_35_1 doi: 10.3390/jfb5040273 – ident: e_1_2_7_37_1 doi: 10.1016/j.ijbiomac.2018.11.186 – ident: e_1_2_7_22_1 doi: 10.7205/MILMED-D-11-00310 – ident: e_1_2_7_30_1 doi: 10.1016/j.polymer.2005.03.072 – ident: e_1_2_7_23_1 doi: 10.1002/mabi.201800209 – ident: e_1_2_7_31_1 doi: 10.1001/jamadermatol.2013.2620 – ident: e_1_2_7_17_1 doi: 10.1016/j.resuscitation.2008.02.019 – ident: e_1_2_7_6_1 doi: 10.1097/TA.0b013e31819634a1 – ident: e_1_2_7_3_1 doi: 10.1007/s40140-014-0063-8 – volume: 17 start-page: 150 year: 2015 ident: e_1_2_7_4_1 article-title: Current status of hemostatic agents and sealants in urologic surgical practice publication-title: Rev Urol – ident: e_1_2_7_7_1 doi: 10.1016/j.actbio.2011.03.003 – ident: e_1_2_7_16_1 doi: 10.1038/aps.2012.159 – ident: e_1_2_7_33_1 doi: 10.1016/j.biomaterials.2008.07.034 – ident: e_1_2_7_12_1 doi: 10.1016/j.jaad.2011.06.028 – ident: e_1_2_7_21_1 doi: 10.1002/(SICI)1097-4652(199905)179:2<142::AID-JCP4>3.0.CO;2-Q – ident: e_1_2_7_36_1 doi: 10.1134/S1560090408070038 – ident: e_1_2_7_10_1 doi: 10.1006/jsre.1996.0379 – volume: 20 start-page: 485 year: 2010 ident: e_1_2_7_25_1 article-title: Radiological and histopathological comparison of microporous polysaccharide hemospheres and oxidized regenerated cellulose in the rabbit brain: a study of efficacy and safety publication-title: Turk Neurosurg – ident: e_1_2_7_19_1 doi: 10.1097/TA.0b013e3181c452b5 – ident: e_1_2_7_11_1 doi: 10.1016/j.athoracsur.2005.03.051 – ident: e_1_2_7_20_1 doi: 10.1016/j.carbpol.2019.05.035 – ident: e_1_2_7_28_1 doi: 10.1039/C6RA20782K – ident: e_1_2_7_34_1 doi: 10.1021/la701281t – ident: e_1_2_7_2_1 doi: 10.1097/01.ta.0000199961.02677.19 – ident: e_1_2_7_32_1 doi: 10.1002/(SICI)1097-4628(19991220)74:13<3186::AID-APP22>3.0.CO;2-Y – ident: e_1_2_7_29_1 doi: 10.1002/adfm.201704452 – ident: e_1_2_7_5_1 doi: 10.1097/TA.0000000000001075 – ident: e_1_2_7_24_1 doi: 10.1097/TA.0b013e31805f7023 – ident: e_1_2_7_14_1 doi: 10.1002/adma.201301034 – ident: e_1_2_7_8_1 doi: 10.1592/phco.29.pt2.8S – ident: e_1_2_7_13_1 doi: 10.1021/acsbiomaterials.8b00453 – ident: e_1_2_7_18_1 doi: 10.1080/10903120601021176 – ident: e_1_2_7_15_1 doi: 10.1021/cm071457b – volume: 2 start-page: 25 year: 2011 ident: e_1_2_7_26_1 article-title: Evaluation of topical hemostatic agents for combat wound treatment publication-title: US Army Med Dep J |
SSID | ssj0029557 |
Score | 2.3762414 |
Snippet | The use of haemostatic agents can provide life‐saving treatment for patients who suffer from massive bleeding in both prehospital and intraoperative... The use of haemostatic agents can provide life-saving treatment for patients who suffer from massive bleeding in both prehospital and intraoperative... |
SourceID | unpaywall pubmedcentral proquest pubmed crossref wiley |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 394 |
SubjectTerms | biodegradation cytocompatibility fibroblast haemorrhage control haemostatic powder Original |
SummonAdditionalLinks | – databaseName: Wiley Online Library - Core collection (SURFmarket) dbid: DR2 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwELYQF3ppi9rS7Uvu48AlKHHsTayeECoCpHJARXBAivzUrtg6q91sV_TXd8bZpN1SUMUliuKJ5ceM_dme-UzIpyHLFAY1JtxLD48yS6Q1PjEi5bbMvFbxBP_r6fDonJ9cissN8rmLhWn5IfoNN7SMOF6jgSs9_8PIx0v00WIlBphnuYhHtGc9dRSTIrJ8AuBmCVKkrFiF0Iun_3N9LroFMG_7SW4twlTdLNVkso5l42R0-IRcddVofVCu9xaN3jM__2J4fGA9n5LHK5BK91ut2iYbLjwj4TjQH-NmVtPfDOG09hQQJB3dwJfIskuVAfVWE7zuoXEUPdbRLczRab20bkYBI9OmnqJq0JFy32tAp_PxnKpg6RKveKIIXWE-fU7OD798OzhKVrc1JAZBSSKk5awQsPyC0hapU04ym3KlZSaM5rlKeSaVkRpQhdM60575AseTUqXC5Xn-gmyGOriXhDLQFkBKzvPc84LlsIAfMlkYW1o7dEwOyG7Xb5VZUZnjjRqTqlvSQKNVsdEG5EMvOm35O_4l9L7r_AqsC49MVHD1Yl4B3oQBCyO-BmSnVYY-GxgNuRA5pBRratILIHP3ekoYjyKDN-QpARkNyMdeoe4r3W7Uj7slquOLk_jy6v9FX5NHDLcOohPSG7LZzBbuLeCrRr-LhvQLMjkjtw priority: 102 providerName: Wiley-Blackwell |
Title | In vitro evaluation of the hyaluronic acid/alginate composite powder for topical haemostasis and wound healing |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fiwj.13285 https://www.ncbi.nlm.nih.gov/pubmed/31845534 https://www.proquest.com/docview/2327941654 https://pubmed.ncbi.nlm.nih.gov/PMC7949266 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/iwj.13285 |
UnpaywallVersion | publishedVersion |
Volume | 17 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVAQN databaseName: PubMed Central (Free e-resource, activated by CARLI) customDbUrl: eissn: 1742-481X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0029557 issn: 1742-4801 databaseCode: RPM dateStart: 20040101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVOVD databaseName: Journals@Ovid LWW All Open Access Journal Collection Rolling customDbUrl: eissn: 1742-481X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0029557 issn: 1742-4801 databaseCode: OVEED dateStart: 20040401 isFulltext: true titleUrlDefault: http://ovidsp.ovid.com/ providerName: Ovid – providerCode: PRVWIB databaseName: KBPluse Wiley Online Library: Open Access customDbUrl: eissn: 1742-481X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0029557 issn: 1742-4801 databaseCode: AVUZU dateStart: 20040101 isFulltext: true titleUrlDefault: https://www.kbplus.ac.uk/kbplus7/publicExport/pkg/559 providerName: Wiley-Blackwell – providerCode: PRVWIB databaseName: Wiley Online Library - Core collection (SURFmarket) issn: 1742-4801 databaseCode: DR2 dateStart: 20040101 customDbUrl: isFulltext: true eissn: 1742-481X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0029557 providerName: Wiley-Blackwell – providerCode: PRVWIB databaseName: Wiley Online Library Open Access customDbUrl: eissn: 1742-481X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0029557 issn: 1742-4801 databaseCode: 24P dateStart: 20040101 isFulltext: true titleUrlDefault: https://authorservices.wiley.com/open-science/open-access/browse-journals.html providerName: Wiley-Blackwell |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bb9MwFLZY-wAvDMRlZVCZy8NeMhLHufhxYp22SYwJUShPwfFFrShJ1KZU49dzTm5TGCAkXqIocSwn-c7xZ_v4O4S8CpkncVOjw62wcIg9R2hlHRW4XMeeTWW1gv_2Ijyd8vNZMGvynOJemFofoptwQ8uo_DUaeKFt7edbU3-92GKcFouDHTIMcYVpQIbTi8ujz_U2SOagOMr1uTdrtIV6z_Z7pBs082a05O1NVsirrVwu-4y26pJOdsmX9mXqSJSvh5syPVQ_ftF5_I-3vUfuNnSVHtX4uk9umewByc4y-n1RrnJ6rRVOc0uBS9L5FVyp9HapVAB0ucTED6WhGLuOAWKGFvlWmxUFtkzLvECQ0Lk033LgqevFmspM0y0me6JIYqFnfUimJ5MPb06dJm-Do5CeOIHQnEUBDMSgtZFrpBFMu1ymwgtUyn3pck9IJVLgFyZNvdQyG6FniaUbGN_3H5FBlmdmj1AGuAHOZCz3LY-YD0P5kIlI6Vjr0DAxIgftv0tUI2qOuTWWSTu4gY-WVB9tRF50RYtayeN3hZ63AEjAznDxRGYm36wTYJ7gunDv14g8rgHRVQN-kQeBD3eiHlS6Aqjh3b-TLeaVljfUKYAjjcjLDlR_a91BhZE_l0jOPp1XJ0_-qcJ9cofh_EEVifSUDMrVxjwDklWmY7LD-CUcj9-zMRm--ziZHI8b4_oJLGcriw |
linkProvider | Unpaywall |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3Na9swFH903aG7lI59pe027ePQi8GWJduCXsZYSfrFDi3rzciWRAKpHBKnof9931MSd6Hb2MUY69nY_ulJvyc9_QTwNeOJpkWNkXDK4aFIImVqF9UyFqZIXKXDDP7FZda_Fqc38mYLjtdrYZb6EN2AG3lGaK_JwWlA-jcvHy0oSYsX8hk8FxmPqU5z8bMLt5QMOp9IuXlEIikrXSHK4-lu3eyNnlDMp5mSO3M_0fcLPR5vstnQHZ3swe6KR7JvS-Bfwpb1r8APPLsbtdOGPYp4s8YxJHlseI9XghAu0zXWQD2mHRlayyipnDK3LJs0C2OnDGksa5sJoceG2t42SCBnoxnT3rAF7cLEiF1il_cark9-XH3vR6sNFaKaeEMklRE8lxgh4cfnsdVWcRMLXalE1pVIdSwSpWtVYcdvqyqpHHc5uXyhY2nTNH0D277x9h0wjoAimbFOpE7kPMUYO-Mqr01hTGa56sHR-seW9UptnDa9GJfrqAMxKAMGPfjcmU6WEht_Mvq0RqdEB6BZDe1tM5-VSAmxTaFFWT14u0Sreww2WELKFEvyDRw7AxLX3izxo2EQ2cZnKiQvPfjSIf6vtzsKdeHvFuXg12k42f9_04-w07-6OC_PB5dnB_CCU6QfcoYOYbudzu17pENt9SHU-gdQTwcR |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zj9MwELaWRQJeOMRVTnM87EtWiWMnsXhCQLVdYIUQK_YBKfKpVpQkalOq5dcz4zSBsoAQL1EUTywfM_Y39vgzIU8zlig81BhxLz08iiSS1vjIiJjbIvFahR38t0fZwTE_PBEnO-RZfxam44cYFtzQMsJ4jQbeWP-Tkc_WGKPFCnGOnOcZeFeIiN4P3FFMikDzCYibRciRsqEVwjCe4dftyegMwjwbKHlxVTXqdK3m820wG2aj8RXyqa9HF4TyeX_V6n3z7ReKx_-s6FVyeYNS6fNOra6RHVddJ9Wkol9n7aKmPyjCae0pQEg6PYUvgWaXKgP6reZ430PrKIasY1yYo029tm5BASTTtm5QN-hUuS81wNPlbElVZeka73iiiF1hQr1BjsevPrw4iDbXNUQGUUkkpOUsF-B_QWnz2CknmY250jIRRvNUxTyRykgNsMJpnWjPfI4DSqFi4dI0vUl2q7pytwlloC4AlZznqec5S8GDz5jMjS2szRyTI7LX91tpNlzmeKXGvOx9Gmi0MjTaiDweRJuOwON3Qo_6zi_BvHDPRFWuXi1LAJwwYuGRrxG51SnDkA0Mh1yIFFLyLTUZBJC6ezulmk0DhTfkKQEajciTQaH-Vrq9oB9_lignHw_Dy51_F31ILrx7OS7fTI5e3yWXGC4jhICke2S3XazcfcBarX4QbOo7wAImgg |
linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Jb9QwFLZgeoALi9imLDLLoZeUxHEWHytE1Vai4sCI4RTs2NaMGJxoJtNR-fW85yxVKCAkLlEUO1acfO_5c_z8PULepCySuKkx4FZYOORRIHRpgzIJuc4jq6Rfwf9wnp7M-Nk8mXd5TnEvTKsPMfxwQ8vw_hoNvNa29fO9qb9d7jBOi-XJTbKX4grThOzNzj8efWm3QbIAxVGuzqN5py00unc8Il2jmdejJW9tXS0vd3K1GjNaPyQd3yVf-860kSjfDreNOix__KLz-B-9vUfudHSVHrX4uk9uGPeAuFNHL5bNuqJXWuG0shS4JF1cwhWvt0tlCUCXK0z80BiKsesYIGZoXe20WVNgy7SpagQJXUjzvQKeulluqHSa7jDZE0USCyPrQzI7fv_p3UnQ5W0ISqQnQSI0Z1kCEzF42iw00gimQy6ViJJS8ViGPBKyFAr4hVEqUpbZDD1LLsPExHH8iExc5cwTQhngBjiTsTy2PGMxTOVTJrJS51qnhokpOei_XVF2ouaYW2NV9JMbeGmFf2lT8mqoWrdKHr-r9LIHQAF2hosn0plquymAeYLrwr1fU_K4BcTQDPhFniQxlGQjqAwVUMN7XOKWC6_lDW0K4EhT8noA1d-e7sBj5M81itPPZ_5k_58afEpuM_x_4CORnpFJs96a50CyGvWiM6Sf8g8oNQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=In+vitro+evaluation+of+the+hyaluronic+acid%2Falginate+composite+powder+for+topical+haemostasis+and+wound+healing&rft.jtitle=International+wound+journal&rft.au=Chen%2C+Yi%E2%80%90Wen&rft.au=Lu%2C+Chia%E2%80%90Hsin&rft.au=Shen%2C+Meng%E2%80%90Han&rft.au=Lin%2C+Shih%E2%80%90Yeh&rft.date=2020-04-01&rft.pub=Blackwell+Publishing+Ltd&rft.issn=1742-4801&rft.eissn=1742-481X&rft.volume=17&rft.issue=2&rft.spage=394&rft.epage=404&rft_id=info:doi/10.1111%2Fiwj.13285&rft_id=info%3Apmid%2F31845534&rft.externalDocID=PMC7949266 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1742-4801&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1742-4801&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1742-4801&client=summon |